Evolution of Technology, Establishment of Program, and Clinical Outcomes in Pediatric Extracorporeal Membrane Oxygenation: The "SickKids" Experience

Artificial Organs

Volumn 37, Issue 1, 2013, Pages 21-28

  Kotani, Yasuhiro ^a   Honjo, Osami ^a   Davey, Lisa ^a   Chetan, Devin ^a   Guerguerian, Anne Marie ^a   Gruenwald, Colleen ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Extracorporeal membrane oxygenation; Pediatric; Team development; Technology

Indexed keywords

OXYGENATION; PATIENT MONITORING; PEDIATRICS; RESUSCITATION;

CLINICAL OUTCOME; EVOLUTION OF TECHNOLOGY; EXTRACORPOREAL LIFE SUPPORTS; EXTRACORPOREAL MEMBRANE OXYGENATION; PROGRAM OUTCOMES; SUPPORT PROGRAMS; TEAM DEVELOPMENT; TEAM EDUCATIONS; TECHNOLOGICAL DEVELOPMENT; TECHNOLOGY;

RESPIRATORY THERAPY;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLEEDING; BLOOD CLOTTING; BLOOD PUMP; CARDIOPULMONARY BYPASS; CENTRIFUGAL PUMP; CLINICAL PRACTICE; COVALENT BOND; EXTRACORPOREAL OXYGENATION; GAS DIFFUSION; HEART SINGLE VENTRICLE; HUMAN; KIDNEY DYSFUNCTION; LUNG DISEASE; MEMBRANE OXYGENATOR; PATIENT SAFETY; PRIORITY JOURNAL; RESUSCITATION;

EID: 84872404121     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12032     Document Type: Article

References (21)

1. Hill JD, O'Brien TG, Murray JJ, etal. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 1972;286:629-634.
2. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976;22:80-93.
3. Bartlett RH. Extracorporeal life support: history and new directions. ASAIO J 2005;51:487-489.
4. Cooper DS, Jacobs JP, Moore L, etal. Cardiac extracorporeal life support: state of the art in 2007. Cardiol Young 2007;17(Suppl. 2):104-115.
5. Gaffney AM, Wildhirt SM, Griffin MJ, Annich GM, Radomski MW. Extracorporeal life support. BMJ 2010;341:c5317.
6. ECMO Registry. Report of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, Michigan, 2012.
7. Iwahashi H, Yuri K, Nose Y. Development of the oxygenator: past, present, and future. J Artif Organs 2004;7:111-120.
8. Lim MW. The history of extracorporeal oxygenators. Anaesthesia 2006;61:984-995.
9. Fleming GM, Gurney JG, Donohue JE, Remenapp RT, Annich GM. Mechanical component failures in 28171 neonatal and pediatric extracorporeal membrane oxygenation courses from 1987 to 2006. Pediatr Crit Care Med 2009;10:439-444.
10. Reed-Thurston D, Qiu F, Undar A, Haidet KK, Shenberger J. Pediatric and neonatal extracorporeal life support technology component utilization: are US clinicians implementing new technology? Artif Organs 2012;36:607-615.
11. Boettcher W, Merkle F, Weitkemper HH. History of extracorporeal circulation: the invention and modification of blood pumps. J Extra Corpor Technol 2003;35:184-191.
12. Thiara AP, Hoel TN, Kristiansen F, Karlsen HM, Fiane AE, Svennevig JL. Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion 2007;22:323-326.
13. Horton S, Thuys C, Bennett M, Augustin S, Rosenberg M, Brizard C. Experience with the jostra rotaflow and QuadroxD oxygenator for ECMO. Perfusion 2004;19:17-23.
14. Bennett M, Horton S, Thuys C, Augustin S, Rosenberg M, Brizard C. Pump-induced haemolysis: a comparison of short-term ventricular assist devices. Perfusion 2004;19:107-111.
15. Haines N, Wang S, Myers JL, Undar A. Comparison of two types of neonatal extracorporeal life support systems with pulsatile and nonpulsatile flow. Artif Organs 2009;33:958-966.
16. Talor J, Yee S, Rider A, Kunselman AR, Guan Y, Undar A. Comparison of perfusion quality in hollow-fiber membrane oxygenators for neonatal extracorporeal life support. Artif Organs 2010;34:E110-116.
17. Health Canada. Health Canada Expert Advisory Panel on DEHP in Medical Devices. 2002.
18. Karle VA, Short BL, Martin GR, etal. Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate. Crit Care Med 1997;25:696-703.
19. Haishima Y, Matsuda R, Hayashi Y, Hasegawa C, Yagami T, Tsuchiya T. Risk assessment of di(2-ethylhexyl)phthalate released from PVC blood circuits during hemodialysis and pump-oxygenation therapy. Int J Pharm 2004;274:119-129.
20. Kurusz M, Wheeldon DR. Risk containment during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg 1990;2:400-409.
21. Karimova A, Robertson A, Cross N, etal. A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standby. Crit Care Med 2005;33:1572-1576.